News & Insights

Subscribe

  • People
  • Offices
    • back
    • Offices
    • North America
      • back
      • North America
      • Atlanta
      • Austin
      • Charlotte
      • Chicago
      • Dallas
      • Denver
      • Houston
      • Los Angeles
      • Miami
      • New York
      • Northern Virginia
      • Sacramento
      • San Francisco
      • Silicon Valley
      • Washington, D.C.
    • Europe & Middle East
      • back
      • Europe & Middle East
      • Abu Dhabi
      • Brussels
      • Dubai
      • Frankfurt
      • Geneva
      • London
      • Paris
      • Riyadh
    • Asia Pacific
      • back
      • Asia Pacific
      • Singapore
      • Sydney
      • Tokyo
  • Capabilities
    • back
    • Capabilities
    • Corporate, Finance and Investments
      • back
      • Corporate, Finance and Investments
      • Overview
      • Activist Defense
      • Capital Markets
      • Construction and Procurement
      • Corporate Governance
      • Emerging Companies and Venture Capital
      • Employee Benefits and Executive Compensation
      • Energy and Infrastructure Projects
      • Financial Restructuring
      • Fund Finance
      • Global Human Capital and Compliance
      • Investment Funds and Asset Management
      • Leveraged Finance
      • Mergers and Acquisitions (M&A)
      • Middle East and Islamic Finance and Investment
      • Private Equity
      • Public Companies
      • Real Estate
      • Structured Finance and Securitization
      • Tax
      • Technology Transactions
    • Government Matters
      • back
      • Government Matters
      • Overview
      • Antitrust
      • Data, Privacy and Security
      • Environmental, Health and Safety
      • FDA and Life Sciences
      • Government Advocacy and Public Policy
      • Government Contracts
      • Healthcare
      • Innovation Protection
      • International Trade
      • National Security and Corporate Espionage
      • Securities Enforcement and Regulation
      • Special Matters and Government Investigations
    • Trial and Global Disputes
      • back
      • Trial and Global Disputes
      • Overview
      • Antitrust
      • Appellate, Constitutional and Administrative Law
      • Bankruptcy and Insolvency Litigation
      • Class Action Defense
      • Commercial Litigation
      • Corporate and Securities Litigation
      • E-Discovery
      • Global Construction and Infrastructure Disputes
      • Innovation Protection
      • Intellectual Property
      • International Arbitration and Litigation
      • Labor and Employment
      • Product Liability
      • Professional Liability
      • Toxic & Environmental Torts
    • Industries / Issues
      • back
      • Industries / Issues
      • Industries
      • Automotive, Transportation and Mobility
      • Energy Transition
      • Energy
      • Financial Services
      • Food and Beverage
      • Higher Education
      • Life Sciences and Healthcare
      • Technology
      • Issues
      • Artificial Intelligence (AI) and Machine Learning
      • Buy American
      • Crisis Management
      • Doing Business in Latin America
      • Environmental Agenda
      • Environmental, Social and Governance (ESG)
      • Focus on Women's Health
      • Russia/Ukraine
      • Special Purpose Acquisition Companies (SPACs)
  • Careers
    • back
    • Careers
    • Lawyers
      • back
      • Lawyers
      • Experienced Lawyers
    • Students
      • back
      • Students
      • Law Students
      • UK Graduate Recruitment
    • Judicial Clerks
      • back
      • Judicial Clerks
      • Judicial Clerks
    • Business Professionals
      • back
      • Business Professionals
      • Business Professionals
  • News & Insights
    • back
    • News & Insights
    • News
      • back
      • News
      • All News
      • Cases & Deals
      • In the News
      • Press Releases
      • Recognitions
    • Events
      • back
      • Events
      • All Events
      • Conferences
      • Speaking Engagements
      • Webinars
    • Insights
      • back
      • Insights
      • All Insights
      • Newsletters
      • Client Alerts
      • Thought Leadership
      • Articles
      • Feature
      • BLOGS
      • Auditor Liability Bulletin
  • About
    • back
    • About
    • Our Firm
      • back
      • Our Firm
      • History
      • Our Values
    • Our Culture
      • back
      • Our Culture
      • Overview
    • Citizenship
      • back
      • Citizenship
      • Overview
      • Pro Bono
      • Community Focus
  • Languages

News & Insights

  • News
    • back
    • News
    • All News
    • Cases & Deals
    • In the News
    • Press Releases
    • Recognitions
  • Events
    • back
    • Events
    • All Events
    • Conferences
    • Speaking Engagements
    • Webinars
  • Insights
    • back
    • Insights
    • All Insights
    • Newsletters
    • Client Alerts
    • Thought Leadership
    • Articles
    • Feature
    • BLOGS
    • Auditor Liability Bulletin
< Back to Bio
Christina M. Markus (Chris)

News 8 results

In the News · Source: Law.com

February 9, 2026
K&S’s Client Alert is referenced in a profile examining the Department of Health and Human Services’ Office of Inspector General’s guidance on direct-to-consumer drug sales

In the News · Source: PharmaCircle

November 25, 2025
Chris Markus provides insight on the FDA’s recent public meeting to discuss FDA PreCheck to accelerate the establishment of high priority new pharmaceutical manufacturing facilities in the U.S. and strengthen the domestic pharmaceutical supply chain

In the News · Source: PharmaVoice

July 18, 2025
K&S's Client Alert is referenced in a profile discussing the FDA publishing 200 complete response letters sent to pharma companies for drugs that were later approved

Recognition

September 19, 2024
King & Spalding Earns Multiple Rankings in LMG Life Sciences 2024 Guide

Recognition

September 21, 2023
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2023 Guide

Recognition

February 10, 2017
BTI Consulting Group Names Chris Markus a 2017 Client Service All-Star

Recognition

November 17, 2016
LMG Life Sciences Names 11 King & Spalding Lawyers Life Sciences Stars

Recognition

July 8, 2016
Legal 500 U.S. Ranks King & Spalding Practices and Lawyers Among the Best in 2016

© 2026 King & Spalding LLP
  • Contact Us
  • Disclaimer
  • Privacy Notice
  • Transparency Disclosure
  • Cookie Policy
  • Copyright Notice
  • Regulatory Notices
  • Fraud Notice
  • Lawyers Alumni Group